PA
UTHR icon

Profund Advisors’s United Therapeutics UTHR Stock Holding History

Profund Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.78M Sell
4,687
-601
-11% -$299K 0.1% 135
2025
Q4 		$2.58M Buy
5,288
+44
+0.8% +$20.5K 0.08% 153
2025
Q3 		$2.2M Sell
5,244
-2,732
-34% -$919K 0.07% 175
2025
Q2 		$2.29M Sell
7,976
-83
-1% -$24.8K 0.08% 161
2025
Q1 		$2.48M Buy
8,059
+151
+2% +$51.7K 0.11% 147
2024
Q4 		$2.79M Sell
7,908
-2,734
-26% -$1M 0.1% 135
2024
Q3 		$3.81M Sell
10,642
-1,996
-16% -$674K 0.14% 105
2024
Q2 		$4.03M Buy
12,638
+5,338
+73% +$1.41M 0.15% 99
2024
Q1 		$1.68M Buy
7,300
+35
+0.5% +$7.9K 0.07% 204
2023
Q4 		$1.6M Sell
7,265
-493
-6% -$114K 0.07% 227
2023
Q3 		$1.75M Sell
7,758
-168
-2% -$38.7K 0.1% 164
2023
Q2 		$1.75M Buy
7,926
+959
+14% +$212K 0.09% 172
2023
Q1 		$1.56M Buy
6,967
+383
+6% +$94.4K 0.1% 177
2022
Q4 		$1.83M Buy
6,584
+45
+0.7% +$11.4K 0.12% 164
2022
Q3 		$1.37M Sell
6,539
-343
-5% -$76.7K 0.1% 184
2022
Q2 		$1.62M Sell
6,882
-960
-12% -$195K 0.1% 176
2022
Q1 		$1.41M Sell
7,842
-342
-4% -$65.2K 0.06% 250
2021
Q4 		$1.77M Sell
8,184
-1,163
-12% -$228K 0.06% 224
2021
Q3 		$1.73M Sell
9,347
-745
-7% -$147K 0.06% 245
2021
Q2 		$1.81M Sell
10,092
-147
-1% -$28K 0.06% 241
2021
Q1 		$1.71M Sell
10,239
-1,158
-10% -$193K 0.07% 221
2020
Q4 		$1.73M Buy
11,397
+1,526
+15% +$200K 0.08% 220
2020
Q3 		$997K Sell
9,871
-1,570
-14% -$172K 0.05% 278
2020
Q2 		$1.38M Buy
11,441
+1,748
+18% +$197K 0.08% 222
2020
Q1 		$919K Sell
9,693
-4,283
-31% -$407K 0.07% 249
2019
Q4 		$1.23M Buy
13,976
+900
+7% +$79.2K 0.05% 298
2019
Q3 		$1.04M Sell
13,076
-727
-5% -$58.5K 0.05% 318
2019
Q2 		$1.08M Sell
13,803
-1,911
-12% -$179K 0.05% 343
2019
Q1 		$1.84M Buy
15,714
+1,281
+9% +$149K 0.09% 211
2018
Q4 		$1.57M Sell
14,433
-4,920
-25% -$570K 0.1% 199
2018
Q3 		$2.48M Buy
19,353
+805
+4% +$99.6K 0.09% 185
2018
Q2 		$2.1M Sell
18,548
-975
-5% -$107K 0.08% 195
2018
Q1 		$2.19M Sell
19,523
-957
-5% -$122K 0.09% 186
2017
Q4 		$3.03M Sell
20,480
-2,082
-9% -$265K 0.12% 153
2017
Q3 		$2.64M Buy
22,562
+992
+5% +$127K 0.11% 161
2017
Q2 		$2.8M Sell
21,570
-3,144
-13% -$392K 0.13% 135
2017
Q1 		$3.35M Buy
24,714
+187
+0.8% +$28.3K 0.15% 108
2016
Q4 		$3.52M Sell
24,527
-2,795
-10% -$357K 0.16% 97
2016
Q3 		$3.23M Sell
27,322
-1,550
-5% -$186K 0.15% 109
2016
Q2 		$3.06M Sell
28,872
-1,430
-5% -$160K 0.15% 110
2016
Q1 		$3.38M Sell
30,302
-8,335
-22% -$1.05M 0.18% 85
2015
Q4 		$6.05M Buy
38,637
+2,557
+7% +$372K 0.29% 54
2015
Q3 		$4.74M Sell
36,080
-4,379
-11% -$702K 0.27% 49
2015
Q2 		$7.04M Sell
40,459
-2,176
-5% -$391K 0.29% 48
2015
Q1 		$7.35M Buy
42,635
+3,461
+9% +$528K 0.29% 48
2014
Q4 		$5.07M Buy
39,174
+4,948
+14% +$638K 0.21% 79
2014
Q3 		$4.4M Buy
34,226
+2,982
+10% +$307K 0.21% 78
2014
Q2 		$2.77M Sell
31,244
-10,450
-25% -$1M 0.12% 138
2014
Q1 		$3.92M Buy
41,694
+6,257
+18% +$640K 0.18% 79
2013
Q4 		$4.01M Buy
35,437
+6,784
+24% +$612K 0.18% 75
2013
Q3 		$2.26M Buy
28,653
+2,061
+8% +$151K 0.12% 123
2013
Q2 		$1.75M Buy
+26,592
New +$1.71M 0.12% 127

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Profund Advisors's UTHR Position: Q1 2026 in Review

Profund Advisors reduced its United Therapeutics (UTHR) stake by 11% in Q1 2026, selling an estimated $299K and leaving 4,687 shares worth $2.78M. The position accounts for 0.1% of the portfolio, ranked #135.

Profund Advisors first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.35M in Q1 2015. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Profund Advisors held 4,687 shares of United Therapeutics worth $2.78M as of Q1 2026.
  • Profund Advisors sold 601 United Therapeutics shares in Q1 2026, an estimated $299K.
  • United Therapeutics made up 0.1% of Profund Advisors's portfolio in Q1 2026, its #135 holding.
  • Profund Advisors first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Profund Advisors's United Therapeutics position peaked at $7.35M in Q1 2015.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.